Filing Details
- Accession Number:
- 0001170362-12-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-03 20:51:38
- Reporting Period:
- 2012-07-02
- Filing Date:
- 2012-07-03
- Accepted Time:
- 2012-07-03 19:51:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1080709 | Arena Pharmaceuticals Inc | ARNA | Pharmaceutical Preparations (2834) | 232908305 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1170362 | W Steven Spector | C/O Arena Pharmaceuticals, Inc. 6166 Nancy Ridge Drive San Diego CA 92121 | Evp, General Counsel & Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-07-02 | 16,666 | $6.00 | 76,254 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2012-07-02 | 22,699 | $4.01 | 98,953 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2012-07-02 | 30,000 | $3.25 | 128,953 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2012-07-02 | 45,000 | $1.49 | 173,953 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-07-02 | 95,000 | $9.96 | 78,953 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-07-02 | 39,365 | $10.04 | 39,588 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-07-03 | 22,300 | $4.01 | 61,888 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-07-03 | 22,300 | $10.05 | 39,588 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2012-07-02 | 16,666 | $0.00 | 16,666 | $6.00 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2012-07-02 | 22,699 | $0.00 | 22,699 | $4.01 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2012-07-02 | 30,000 | $0.00 | 30,000 | $3.25 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2012-07-02 | 45,000 | $0.00 | 45,000 | $1.49 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2012-07-03 | 22,300 | $0.00 | 22,300 | $4.01 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
33,334 | 2014-01-18 | No | 4 | M | Direct | |
37,301 | 2019-03-17 | No | 4 | M | Direct | |
70,000 | 2020-03-17 | No | 4 | M | Direct | |
255,000 | 2021-03-15 | No | 4 | M | Direct | |
15,001 | 2019-03-17 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 11, 2012.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $9.79 and $10.10 per share, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this Form 4.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $10.00 and $10.10 per share, inclusive.
- The options vested in four equal annual installments on January 18, 2005, 2006, 2007 and 2008, and were immediately exercisable.
- The options vest in four equal annual installments, and are exercisable once vested. The first, second and third installments became exercisable on March 17, 2010, 2011 and 2012, and the fourth installment vests on March 17, 2013.
- The options vest in four equal annual installments, and are exercisable once vested. The first and second installments became exercisable on March 17, 2011 and 2012, and the third and fourth installments vest on March 17, 2013 and 2014.
- The options vest in four equal annual installments, and are exercisable once vested. The first installment became exercisable on March 15, 2012, and the second, third and fourth installments vest on March 15, 2013, 2014 and 2015.